RE:RE:RE:New MDR casesJF,
Clinically, we’re seeing a lot of that in the IV drug user population.
Even if they are using clean needles, they tend to reuse filters which harbour the virus. It’s leading to an epidemic of a sort.
I have no concerns that Ibalizumab will have a market...it’s up to the reps to get it out there.
As for the share price rise the past few days, I agree it is a reaction to the article.
Luc, known to be conservative, is stating the blue sky speciality pharma case for TH.
Why wouldn’t new buyers pay 5% more tomorrow if the CEO is confident in huge revenues and a few more drugs down the line?
bfw
jfm1330 wrote: Cases of patients using Truvada as PrEP are reported in the litterature, but be sure there are transmission in a lot of other case.
People uninfected or already infected not taking any ARV drugs. Infected patients already infected, but on drugs the MDR virus resist to.
Remember. Some MDR patients got there because they were in many clinical trials using drugs as monotherapy, but many other got there because they had poor behavior concerning adherence. The same pattern of irresponsible conduct can lead some to have unprotected relations with unaware partners.
All that to say that these MDR strains are still transmitted, so no need for the long process of drug resistance to unfold in the patient body over the years. He can be given an already made MDR virus in one shot.